SPONSOR
GeneCradle Inc
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 1, Phase 2
GeneCradle Inc is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Hypertriglyceridemia, Familial, Pompe Disease (Late-onset).
The trial portfolio spans Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — GeneCradle Inc
How many clinical trials has GeneCradle Inc sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by GeneCradle Inc, of which 2 are actively recruiting participants. These trials cover conditions including Hypertriglyceridemia, Familial, Pompe Disease (Late-onset). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does GeneCradle Inc research focus on?
GeneCradle Inc clinical trials span Hypertriglyceridemia, Familial, Pompe Disease (Late-onset). The research pipeline includes Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a GeneCradle Inc clinical trial?
To participate in a GeneCradle Inc trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all GeneCradle Inc trials with current recruitment status updated daily.
Clinical Trials by GeneCradle Inc
NCT05860569 Phase 1
Recruiting
Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreatitis
Hypertriglyceridemia, Familial
NCT06391736 Phase 1, Phase 2
Recruiting
Evaluation of the Safety and Efficacy of Late-onset Pompe Disease Gene Therapy Drug
Pompe Disease (Late-onset)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology